Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

undifferentiated carcinoma of the corpus uteri - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

undifferentiated carcinoma of the corpus uteri

MONDO:0016267

Also known as:body of uterus undifferentiated carcinomaendometrial undifferentiated carcinoma

Find Clinical TrialsTrials

Overview

Undifferentiated carcinoma of the corpus uteri is a rare cancer of corpus uteri presenting as a large, polypoid, intraluminal mass with necrosis, composed of small to intermediate-size, relatively uniform, dyshesive cells displaying no differentiation. It usually presents with dysfunctional bleeding or vaginal discharge and, less often, abdominal pain. Association with Lynch syndrome was reported.

Clinical Trials6 registered · 2 recruiting

Diagnosis

Biomarker and diagnostic research for undifferentiated carcinoma of the corpus uteri has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

6 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, procedural interventions, other interventions, and biologic therapy. Pipeline includes 2 PHASE3, 3 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT05112601](https://clinicaltrials.gov/study/NCT05112601)

Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 8:34 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:213721

GARD

Genetic and Rare Diseases Info Center

GARD:20480

Questions for Your Care Team

→Are any of the 6 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Patient case studies	18	36%
Testing and diagnosis research	10	20%
Research summaries	7	14%
Disease patterns and progression	5	10%
New treatment approaches	4	8%
Laboratory research	3	6%
Clinical study results	2	4%
Other research	1	2%

undifferentiated carcinoma of the corpus uteri

Overview

Diagnosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications